tDCS and Pharmacotherapy on Pain Management in Patients

Effectiveness of Transcranial Direct Current Stimulation and Pharmacotherapy on Pain Management in Patients with Chronic Pain

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211026052879N1

Enrollment

Registered

2021-11-18

Start date

2020-06-21

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain. Other chronic pain

Interventions

Intervention 1: Intervention group: Pharmacotherapy: Pharmacotherapy involved taking 600 mg of gabapentin twice a day (300 mg in the morning and 300 mg at night) for three weeks. Intervention 2: Inter

Eligibility

Sex/Gender

Female

Age

35 Years to 60 Years

Inclusion criteria

Inclusion criteria: Suffering from chronic pain Being female Age range of 35 to 60 years Holding at least a school completion certificate being interested in participation in the intervention treatment

Exclusion criteria

Exclusion criteria: Suffering from severe psychological diseases in terms of diagnostic and statistical psychological disorder guidance

Design outcomes

Primary

Measure	Time frame
Pain management. Timepoint: Post-test. Method of measurement: The McGill Pain Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtefeh Lotfi Jabali

Islamic Azad University

atlotfi@yahoo.com+98 21 7650 5015

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026